Novogene Co., Ltd. (SHA:688315)
17.36
-0.65 (-3.61%)
Nov 17, 2026, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 7.03 billion as of November 16, 2026. It is the 9,391st most valuable company in the world and the 2,018th biggest in China. Its market cap has increased by 16.82% in one year.
Market Cap
7.03B
Enterprise Value
5.37B
Revenue
2.30B
Global Rank
Country Rank
#2,018 China
PE Ratio
46.84
ChartMarket Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 7.03B, a decrease of -35.87%. That is a compound annual growth rate of -7.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 7.03B | 30.72% |
| Dec 31, 2025 | 5.38B | 6.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 7.65B |
| InventisBio | 7.64B |
| Jiangxi Fushine Pharmaceutical | 7.33B |
| BeBetter Med | 7.30B |
| Daan Gene | 7.28B |
| Aurisco Pharmaceutical | 7.17B |
| Chengdu Easton Biopharmaceuticals | 7.08B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 6.96B |